VIP10

VIP10 is a research-use peptide preparation commonly associated with VIP, or vasoactive intestinal peptide. VIP is a 28-amino-acid neuropeptide studied for immune signaling, inflammation-response pathways, smooth-muscle activity, gut and airway research, vascular signaling, and neuroendocrine communication.

Research on VIP-related peptides has most commonly focused on immune balance, inflammation response, airway and smooth-muscle pathways, gut-barrier research, vascular relaxation, nervous-system signaling, and cellular stress response. Published reviews describe VIP as a neuropeptide with broad immunomodulatory activity through VPAC receptor pathways, including VPAC1 and VPAC2.

VIP10 is commonly studied for:

• Immune signaling — how immune cells communicate and regulate response

• Inflammation response — how cells manage stress-related inflammatory signals

• Airway research — pathways connected to bronchial and respiratory smooth-muscle activity

• Gut-function research — how intestinal signaling, secretion, and barrier pathways are regulated

• Vascular response — how blood-vessel relaxation and circulation-related signals are studied

• Neuroendocrine signaling — how nervous-system and hormone-related pathways interact

• VPAC receptor activity — how VIP-related peptides interact with VPAC1 and VPAC2 pathways

VIP10 is commonly studied because VIP-related signaling appears to connect the nervous, immune, gastrointestinal, vascular, and respiratory systems. Research describes VIP as having anti-inflammatory and immune-regulating activity, including effects on cytokine balance, T-cell differentiation, innate immune-cell activity, and inflammatory signaling cascades.

For research use only. Not for human consumption, medical use, diagnostic use, or therapeutic application.